JANE STREET GROUP, LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,099,000
-10.2%
88,482
-52.7%
0.01%0.0%
Q1 2019$4,566,000
+804.2%
187,257
+463.0%
0.01%
+700.0%
Q3 2018$505,000
-72.1%
33,259
-69.1%
0.00%
-75.0%
Q2 2018$1,808,000
+134.2%
107,730
+127.9%
0.00%
+100.0%
Q1 2018$772,000
-76.0%
47,281
-81.2%
0.00%
-80.0%
Q4 2017$3,217,000
+137.1%
251,306
+127.6%
0.01%
+150.0%
Q3 2017$1,357,000
+534.1%
110,397
+331.5%
0.00%
+300.0%
Q2 2017$214,000
+43.6%
25,585
+53.2%
0.00%0.0%
Q1 2017$149,000
-38.2%
16,700
-39.0%
0.00%0.0%
Q4 2016$241,000
-75.8%
27,396
-81.4%
0.00%
-75.0%
Q3 2016$994,000
+2912.1%
147,153
+1202.0%
0.00%
Q1 2016$33,000
-65.6%
11,302
-50.4%
0.00%
Q4 2015$96,000
-40.7%
22,800
-36.0%
0.00%
-100.0%
Q3 2015$162,000
+19.1%
35,627
-6.8%
0.00%0.0%
Q3 2014$136,000
-1.4%
38,219
+26.2%
0.00%
-50.0%
Q2 2014$138,00030,2790.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
BVF INC/IL 9,719,589$60,456,00010.40%
KOPP INVESTMENT ADVISORS LLC 2,808,537$17,470,0006.42%
Redmile Group, LLC 3,669,593$22,825,0003.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,585,406$65,841,0003.06%
QVT Financial LP 2,878,600$17,905,0001.22%
APEX CAPITAL, LLC 2,500,000$15,550,0001.12%
FBR & Co. 113,500$706,0001.07%
Artal Group S.A. 3,000,000$18,660,0000.61%
Perimeter Capital Partners, LLC 486,478$3,026,0000.56%
Orbimed Advisors 4,831,600$30,053,0000.54%
View complete list of ARRAY BIOPHARMA INC shareholders